Aptus Value Housing Finance India Ltd
NSE: APTUSCompany page on Cofacto
Open the Aptus Value Housing Finance India Ltd page

Aptus Value Housing Finance India Ltd Q2 FY27 Results Analysis: PAT Jumps 18%, Credit Costs Breach Guidance

Cofacto Research Published November 04, 2026 4 min read
Positive

Aptus Value Housing Finance India Ltd's Q2 FY27 numbers came in strong, with revenue of Rs. 634.67 Cr (+14.63% YoY) and PAT growth of +18.02% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateNovember 04, 2026
Revenue (Q2)Rs. 634.67 Cr (+14.63% YoY)
PAT (Q2)Rs. 267.38 Cr (+18.02% YoY)
EPS (Q2)Rs. 5.34 (+17.62% YoY)

Quarter Snapshot

Consolidated PAT grew 18.02% YoY to Rs.267.38 Cr with net income margin up 19.18% YoY, powered by finance costs rising only 3.91% against 16.51% interest income growth, and ROE of 20.07% is on track against the 20%+ target. The key tension is credit cost: impairment rose 58.19% YoY in H1 with the proxy at 0.74% annualized, above the guided 0.5% ±10 bps band, while opex growth of 29.77% lifted cost-to-income by 138 bps. AUM and disbursement guidance cannot be assessed from the filing, leaving the 22-24% AUM growth target unverified this quarter.

Q2 FY27 Expectations vs Results

DriverExpected before resultsWhat happenedVerdict
AUM/disbursements "set to re-enter or press the guided 22–24% band"directionAUM/disbursements not disclosed in the filing; loans +4.80% over H1; total income +14.90% YoY H1 — filing basisNot observable
Spread "flat-to-slightly-compressing"; CoF broadly stabledirectionSpread % not disclosed; finance costs +3.91% vs interest income +16.51%; net income margin +19.18% YoY — better than the compressing case on the computable basisPartially
Credit cost hinges on NBFC normalization vs 0.5%±10 bpsdirectionImpairment +31.98% YoY Q2; proxy 0.74% H1; GNPA flat, PCR up to 25.50% — stock stable, run-rate elevatedPartially
No adverse sector regulation inside the windowdirectionFiling shows routine RBI/NHB framework compliance; unmodified review opinionPlayed out
First Interim Dividend (record date Nov 13)declaredRs.2/share declared; Rs.100.17 Cr; 18.96% of H1 PATPlayed out
Reconcile GNPA 1.70% (presentation) vs 1.42% (Q1 filing)reconciliationQ2 filing basis: 1.52% GNPA / 1.14% NNPA / 25.50% PCR — basis gap persists, unexplained in the filingPartially
NHB Rs.500 Cr refinance drawdown; Q2 branch additions (20–23); opex/AUM vs 2.6–2.8%statusNone addressed in the filing (AUM-basis ratios not computable) — remain open for the callNot observable

Management Guidance vs Delivery

What management saidWhat happenedVerdict
AUM growth 22–24% FY27 (~Rs.16,000 Cr)AUM not disclosed in the filing; loans +4.80% over H1; total income +14.90% YoY H1Too Early
ROE 20%+20.07% annualized (2×H1 consol PAT / avg net worth)On Track
First interim dividend FY27 — to be considered Nov 4Declared Rs.2/shareMet

Key Numbers, Quarter by Quarter

MetricQ2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
AUM (Rs. Cr)11,76712,33013,10713,648not disclosed
Disb. (Rs. Cr)9631,0301,2421,053not disclosed
PAT (Rs. Cr)226.55239261260.94267.38
RoA %7.97.98.27.87.82
RoE %20.020.221.220.420.07
Spread %8.98.99.09.0not disclosed
CoB %8.48.38.18.0not disclosed
Branches321335339372not disclosed

Key Investment Insights

Key Positives

  • Consolidated PAT grew 18.02% YoY to Rs.267.38 Cr in Q2; H1 PAT grew 18.51% YoY to Rs.528.32 Cr
  • Net income margin grew 19.18% YoY to Rs.463.22 Cr as finance costs rose only 3.91% YoY against 16.51% interest income growth
  • PPOP grew 16.59% YoY to Rs.364.17 Cr in Q2
  • GNPA stable at 1.52% with PCR on stage-3 assets improved to 25.50% from 25.0% at Q1; LCR at 196.29%
  • Loans grew 4.80% in H1 to Rs.12,501.72 Cr while gross D/E improved to 1.53 from 1.56 and liquidity buffer rose 25.02% to Rs.1,038.78 Cr
  • Annualized consolidated ROE at 20.07%, on track against management's 20%+ target
  • First interim dividend of Rs.2/share declared (Rs.100.17 Cr, 18.96% of H1 PAT)
  • Subsidiary Aptus Finance India contributed Rs.66.66 Cr (24.93% of consolidated PAT) vs Rs.24.69 Cr a year ago

Risk Factors

  • Impairment charges rose 31.98% YoY in Q2 and 58.19% YoY in H1; H1 impairment already equals 73.76% of FY26's full-year charge, with the annualized run-rate ~47% above FY26
  • Credit-cost proxy of 0.74% H1 annualized (0.76% Q2) runs above the guided 0.5% ±10 bps band
  • Opex grew 29.77% YoY, lifting cost-to-income to 15.21% in H1 from 13.83% in H1 FY26
  • Standalone PAT declined 0.56% YoY due to a base effect in other income (Rs.35.09 Cr year-ago vs Rs.11.37 Cr now)
  • GNPA disclosure basis gap between presentation (1.70% at Q1) and filing (1.42% at Q1) remains unexplained in the filing
Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by Cofacto — AI research platform for Indian stocks, every claim cited from primary filings

Login Now